SCHEMBL26549574

SCHEMBL26549574

COc1ccnc(C(C)C)c1F

nearest known ligand 0.35

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.35
CYP3A4 P08684 3/20 0.35
CYP2D6 P10635 3/20 0.35
ALDH1A1 P00352 1/20 0.35
ACHE P22303 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
KDM1A O60341 1/20 0.35
ACVR2A P27037 1/20 0.35
TGFBR2 P37173 1/20 0.35
CYP2C19 P33261 2/20 0.34
USP2 O75604 1/20 0.34
TSHR P16473 1/20 0.34
KRAS P01116 1/20 0.34
SOS1 Q07889 1/20 0.34
FGFR2 P21802 1/20 0.33
TRPA1 O75762 2/20 0.33
CYP2C9 P11712 1/20 0.33
PDGFRB P09619 1/20 0.32
PDGFRA P16234 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20928768 0.78 ACHE (0.36) ACHEL3MBTL1ACVR2ATGFBR2FGFR2
SCHEMBL19203777 0.78 ACHE (0.36) ALDH1A1ACHEL3MBTL1ACVR2ATGFBR2
SCHEMBL31278345 0.78 CDK1 (0.36) ACHEL3MBTL1ACVR2ATGFBR2FGFR2
SCHEMBL19629678 0.77 FGFR2 (0.36) ALDH1A1ACHEL3MBTL1ACVR2ATGFBR2
SCHEMBL25791763 0.77 HPGD (0.38) ACHEL3MBTL1ACVR2ATGFBR2FGFR2
SCHEMBL19769065 0.77 IKBKB (0.39) ALDH1A1ACHEL3MBTL1ACVR2ATGFBR2
SCHEMBL11991739 0.77 DRD1 (0.34) CYP3A4ACHEL3MBTL1ACVR2ATGFBR2
SCHEMBL21736901 0.75 TDO2 (0.33)
SCHEMBL25791543 0.74 FGFR2 (0.35) ALDH1A1ACHEL3MBTL1ACVR2ATGFBR2
SCHEMBL23624591 0.74 MAOA (0.40) CYP1A2CYP3A4CYP2D6ALDH1A1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023196975-A1 COMPOUNDS THAT INTERACT WITH RAS SUPERFAMILY PROTEINS FOR TREATMENT OF CANCERS, INFLAMMATORY DISEASES, RASOPATHIES, AND FIBROTIC DISEASE SHY THERAPEUTICS, LLC (US) 2023-10-12 WO disclosed